NCT01711190

Brief Summary

The aim of this project:

  1. 1.Confirming the modification in corneal astigmatism after trabeculectomy with MMC and intracameral administration of bevacizumab.
  2. 2.Medium-term follow up (6 months) of the induced corneal astigmatism.
  3. 3.Investigating correlations between postoperative astigmatism, particularly with the postoperative IOP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 24, 2012

Completed
8 months until next milestone

First Posted

Study publicly available on registry

October 22, 2012

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

December 20, 2024

Status Verified

December 1, 2024

Enrollment Period

10 months

First QC Date

February 24, 2012

Last Update Submit

December 17, 2024

Conditions

Keywords

glaucomatrabeculectomyastigmatismintraocular pressure

Outcome Measures

Primary Outcomes (1)

  • Change in ocular cylinder and axis untill 6 months after trabeculectomy.

    Comparing the change in corneal cylinder, axis and IOP before the operation and 1,3 and 6 months after the operation. We will compare these vectors by vector analyses.

    pre-operative until 6 months post-operative

Interventions

Filtering surgery to reduce the intra-ocular pressure.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients having a primary trabeculectomy between January and April 2012 for glaucoma that was not adequately controlled with maximal tolerated medical therapy and/or laser therapy.

You may qualify if:

  • Primary open angle glaucoma
  • Normal tension glaucoma
  • Pseudoexfoliation glaucoma
  • Pigment dispersion glaucoma

You may not qualify if:

  • Patients who refuse to sign the informed consent.
  • Patients with primary angle closure glaucoma (PACG).
  • Patients younger than 18 years old.
  • Other ocular diseases besides glaucoma.
  • Significant corneal opacities.
  • Refractive error more than + or -6.00 diopters.
  • Visual acuity less than 0.05
  • Previous intra-ocular surgery (except cataract surgery more than six months preceding the trabeculectomy).
  • Laser treatment for glaucoma within 6 months of the surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sint-Raphaël hospital

Leuven, Vlaams-Brabant, 3000, Belgium

Location

MeSH Terms

Conditions

GlaucomaAstigmatism

Interventions

Trabeculectomy

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesRefractive Errors

Intervention Hierarchy (Ancestors)

Filtering SurgeryOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Heleen Delbeke, MD

    UZ Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 24, 2012

First Posted

October 22, 2012

Study Start

January 1, 2012

Primary Completion

November 1, 2012

Study Completion

December 1, 2012

Last Updated

December 20, 2024

Record last verified: 2024-12

Locations